Ferraprox Advisory Cmte: Can Risk Management Overcome Safety, Dosing Worries?
This article was originally published in The Pink Sheet Daily
Executive Summary
ApoPharma's transfusional iron overload treatment has been approved in Europe since 1999, but FDA sent a "complete response" letter in 2009.